Right-sized multi-product manufacturing for biologics | AIChE

Right-sized multi-product manufacturing for biologics

The COVID pandemic has emphasized the need for local, agile pharmaceutical manufacturing, particularly for biologics and vaccines. This webinar presents a disruptive approach to biologics manufacturing based on small-scale, modular manufacturing technologies, which could enable the regional production of protein-based therapeutics, vaccines, and reagents.

Presenter


Webinar content is available with the kind permission of the author(s) solely for the purpose of furthering AIChE’s mission to educate, inform and improve the practice of professional chemical engineering. The content reflects the views, opinions, and recommendations of the presenters. AIChE does not warrant or represent, expressly or by implication, the correctness or accuracy of the content of the information presented. All other uses are forbidden without the express consent of the author(s). For permission to re-use, please contact chemepermissions@aiche.org. Attendee contact information, including email addresses, will be shared with AIChE, with the option to unsubscribe from future communications.

  • AIChE Pro Members - Free
  • AIChE Graduate Student Members - Free
  • AIChE Undergraduate Student Members - Free
  • AIChE Explorer Members - $109.00
  • Non-Members - $109.00
Do you already own this? Log In for instructions on accessing this content.
  • Source:
    PD2M - Pharmaceutical Discovery, Development and Manufacturing Forum
  • Language:
    English
  • Skill Level:
    Intermediate
  • Duration:
  • PDHs:
    0.00